CD24 and hepatocellular carcinoma: Once internalized by hepatocellular carcinoma (HCC) cells, the nanosphere-AntiCD24 selectively targets HCC cells that overexpress CD24, facilitating the transport of the CD24 protein to the lysosome for degradation.